- Home
- PCVX vs CR Comparison
PCVX vs CR Comparison
Compare PCVX & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- CR
- Stock Information
- Founded
- PCVX 2013
- CR 1855
- Country
- PCVX United States
- CR United States
- Employees
- PCVX N/A
- CR N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- CR Metal Fabrications
- Sector
- PCVX Health Care
- CR Industrials
- Exchange
- PCVX Nasdaq
- CR Nasdaq
- Market Cap
- PCVX 9.6B
- CR 8.9B
- IPO Year
- PCVX 2020
- CR N/A
- Fundamental
- Price
- PCVX $37.76
- CR $153.86
- Analyst Decision
- PCVX Strong Buy
- CR Strong Buy
- Analyst Count
- PCVX 9
- CR 6
- Target Price
- PCVX $147.50
- CR $174.80
- AVG Volume (30 Days)
- PCVX 1.6M
- CR 368.7K
- Earning Date
- PCVX 05-07-2025
- CR 04-21-2025
- Dividend Yield
- PCVX N/A
- CR 0.60%
- EPS Growth
- PCVX N/A
- CR 13.55
- EPS
- PCVX N/A
- CR 5.05
- Revenue
- PCVX N/A
- CR $2,131,200,000.00
- Revenue This Year
- PCVX N/A
- CR $9.28
- Revenue Next Year
- PCVX N/A
- CR $6.57
- P/E Ratio
- PCVX N/A
- CR $30.30
- Revenue Growth
- PCVX N/A
- CR 14.45
- 52 Week Low
- PCVX $30.12
- CR $128.50
- 52 Week High
- PCVX $121.06
- CR $188.52
- Technical
- Relative Strength Index (RSI)
- PCVX 15.46
- CR 44.81
- Support Level
- PCVX $68.36
- CR $150.41
- Resistance Level
- PCVX $76.61
- CR $161.47
- Average True Range (ATR)
- PCVX 3.45
- CR 4.44
- MACD
- PCVX -2.06
- CR 0.35
- Stochastic Oscillator
- PCVX 16.43
- CR 43.96
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.